Legacy Advisors, LLC Repligen Corp Transaction History

Legacy Advisors, LLC

$911 Million
Q1 2025

A detailed history of Legacy Advisors, LLC transactions in Repligen Corp stock. As of the latest transaction made, Legacy Advisors, LLC holds 6,107 shares of RGEN stock, worth $721,053. This represents 0.09% of its overall portfolio holdings.

Number of Shares

6,107

Previous 6,200 1.5%

Holding current value

$721,053

Previous $892,000 12.89%

% of portfolio

0.09%

Previous 0.09%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 22, 2025	SELL	$127.24 - $174.24 $11,833 - $16,204	-93 Reduced 1.5%	6,107 $777,000
Q4 2024 Feb 14, 2025	BUY	$123.41 - $160.92 $84,659 - $110,391	686 Added 12.44%	6,200 $892,000
Q3 2024 Nov 13, 2024	SELL	$119.79 - $167.35 $26,114 - $36,482	-218 Reduced 3.8%	5,514 $820,000
Q2 2024 Jul 30, 2024	BUY	$120.0 - $182.95 $160,560 - $244,787	1,338 Added 30.45%	5,732 $722,000
Q1 2024 Apr 30, 2024	BUY	$170.78 - $208.42 $53,795 - $65,652	315 Added 7.72%	4,394 $808,000
Q4 2023 Feb 12, 2024	BUY	$114.17 - $185.35 $1,940 - $3,150	17 Added 0.42%	4,079 $733,000
Q3 2023 Nov 14, 2023	BUY	$138.78 - $176.51 $27,894 - $35,478	201 Added 5.21%	4,062 $645,000
Q2 2023 Jul 20, 2023	BUY	$138.42 - $180.31 $78,899 - $102,776	570 Added 17.32%	3,861 $546,000
Q1 2023 May 01, 2023	BUY	$154.26 - $198.1 $132,200 - $169,771	857 Added 35.21%	3,291 $554,000
Q4 2022 Feb 01, 2023	BUY	$162.42 - $220.56 $178,174 - $241,954	1,097 Added 82.05%	2,434 $412,000
Q3 2022 Nov 09, 2022	BUY	$160.42 - $256.21 $214,481 - $342,552	1,337 New	1,337 $250,000

Others Institutions Holding RGEN

# of Institutions

494

Shares Held

57.6M

Call Options Held

75.6K

Put Options Held

521K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.55B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Advisors, LLC with notifications on news.

Account

Legacy Advisors, LLC Repligen Corp Transaction History